Advertisement
Screener

RECURSION PHARMACEUTICALS, INC. (RXRX) Auditor

RECURSION PHARMACEUTICALS, INC. Auditor

The independent registered public accounting firm that signed the audit report in each annual report on Form 10-K, newest first. PCAOB firm ID and the internal-control attestation are as tagged on the cover from fiscal 2021; earlier rows come from the signed report text.

  • 2026-02-25: Fiscal year end 2025-12-31; Auditor PricewaterhouseCoopers LLP; PCAOB firm ID 238; Location Seattle, Washington.
  • 2025-02-28: Fiscal year end 2024-12-31; Auditor PricewaterhouseCoopers LLP; PCAOB firm ID 238; Location Seattle, Washington.
  • 2024-02-29: Fiscal year end 2023-12-31; Auditor Ernst & Young LLP; PCAOB firm ID 42; Location Salt Lake City, Utah.
  • 2023-02-27: Fiscal year end 2022-12-31; Auditor Ernst & Young LLP; PCAOB firm ID 42; Location Salt Lake City, Utah.
FiledFiscal year endAuditorPCAOB firm IDLocationInternal-control attestation
2026-02-252025-12-31PricewaterhouseCoopers LLP238Seattle, WashingtonYes
2025-02-282024-12-31PricewaterhouseCoopers LLP238Seattle, WashingtonYes
2024-02-292023-12-31Ernst & Young LLP42Salt Lake City, UtahYes
2023-02-272022-12-31Ernst & Young LLP42Salt Lake City, UtahYes
2022-03-232021-12-31Ernst & Young LLP42Salt Lake City, UtahNo

Similar stocks

Stock NameCountryMarket CapPE Ratio
Kodiak Sciences Inc. (KOD)United States$2.090B-10.12
ADMA BIOLOGICS, INC. (ADMA)United States$2.131B11.16
Vericel Corp (VCEL)United States$2.011B93.97
BIOCRYST PHARMACEUTICALS INC (BCRX)United States$2.175B-6.63
Vir Biotechnology, Inc. (VIR)United States$1.814B-6.85
Greenland Mines Ltd (GRML)United States$2.362B
NOVAVAX INC (NVAX)United States$1.748B-6.26
Hemab Therapeutics Holdings, Inc. (COAG)United States$1.672B
Immunocore Holdings plc (IMCR)$1.613B-90.43
Beam Therapeutics Inc. (BEAM)United States$2.549B-41.51